Classically, chronic urticaria has been treated following a stepwise approach where Omalizumab and other immunosuppressants occupy the last step. Omalizumab and Methotrexate have both been used separately for the treatment of urticaria1,2 . We believe combination treatment with both agents is a valuable alternative for refractory chronic urticaria and other related diseases such as urticarial vasculitis. Here we report on two patients who responded to the combination treatment.
|Number of pages||2|
|Journal||Clinical and Experimental Dermatology|
|Early online date||29 Jun 2020|
|Publication status||Published - Mar 2021|
ASJC Scopus subject areas